- Exchange: Venture
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Patient Monitoring Equip
Biosign Technologies Inc
+ Add to WatchlistBIO:CN
0.0250 CAD 0.00000.00%As of 15:56:43 ET on 05/17/2013.
Snapshot for Biosign Technologies Inc (BIO)
| Open: | - | Day's Range: | - | Volume: | 49,400 |
|---|---|---|---|---|---|
| Previous Close: | 0.0250 | 52wk Range: | 0.0200 - 0.1000 | 1-Yr Rtn: | - |
Key Statistics for BIO
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPTSX | - |
| Earnings Per Share (ttm) | -0.0800 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M CAD) | 2.81 |
| Shares Outstanding (M) | 112.32 |
| 30 Day Average Volume | 34,340 |
| Price/Book (mrq) | 1.3580 |
| Price/Sale (ttm) | 13.8057 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 05/28/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BIO
Company Profile & Key Executives for BIO
Biosign Technologies, Inc. develops and manufactures medical devices. The Company's product is an Internet-based synthetic test & measurement system for blood pressure assessment.
| Robert KaulPresident/CEO | William Randolph Polley "Randy"Chief Financial Officer |
| Christian SleightChief Technology Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
BIO News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page